0001209191-18-003963.txt : 20180117 0001209191-18-003963.hdr.sgml : 20180117 20180117164023 ACCESSION NUMBER: 0001209191-18-003963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180116 FILED AS OF DATE: 20180117 DATE AS OF CHANGE: 20180117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18531862 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-16 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, COO Common Stock 2018-01-16 4 M 0 2125 96.87 D 43013 D Common Stock 2018-01-16 4 S 0 825 155.80 D 42188 D Common Stock 2018-01-16 4 S 0 400 157.02 D 41788 D Common Stock 2018-01-16 4 S 0 400 158.11 D 41388 D Common Stock 2018-01-16 4 S 0 500 159.29 D 40888 D Common Stock 5306 I 401(k) Stock Option (Right to Buy) 96.87 2018-01-16 4 M 0 2125 0.00 D 2024-07-14 Common Stock 2125 4250 D Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $155.80 (range $155.32 to $156.26). Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $157.02 (range $156.62 to $157.50). Open market sales reported on this line occurred at a weighted average price of $158.11 (range $157.77 to $158.67). Open market sales reported on this line occurred at a weighted average price of $159.29 (range $158.96 to $159.65). The option vests in 16 quarterly installments from 7/15/2014. /s/ Omar White, Attorney-in-Fact 2018-01-17